<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#">
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 14:49:07 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:25:05 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42232-9 PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The dose of warfarin sodium tablets must be individualized by monitoring the PT/INR. Not all factors causing warfarin dose variability are known. The maintenance dose needed to achieve a target PT/INR is influenced by:\n●\n     Clinical factors including age, race, body weight, sex, concomitant medications, and comorbidities and\n●\n     Genetic factors (CYP2C9 and VKORC1 genotypes).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Alternative Recommended</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Even in the absence of the HLA-B*5701 allele, it is important to permanently discontinue abacavir and not rechallenge with abacavir if a hypersensitivity reaction cannot be ruled out on clinical grounds, due to the potential for a severe or even fatal reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Use specific</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:43:51 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 14:53:37 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">In CYP2C19 poor metabolizers, citalopram steady state Cmax and AUC was increased by 68% and 107%, respectively.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 14:54:20 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:28:54 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Even in the absence of the HLA-B*5701 allele, it is important to permanently discontinue abacavir and not rechallenge with abacavir if a hypersensitivity reaction cannot be ruled out on clinical grounds, due to the potential for a severe or even fatal reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Added test results (or categorize as poor?)</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">PATIENTS TESTING POSITIVE FOR THE ALLELE SHOULD NOT BE TREATED WITH CARBAMAZEPINE EXTENDED-RELEASE CAPSULES UNLESS THE BENEFIT CLEARLY OUTWEIGHS THE RISK</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:33:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">homozygous for non-functional alleles</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">HLA-B*5701-negative patients may develop a suspected hypersensitivity reaction to abacavir; however, this occurs significantly less frequently than in HLA-B*5701-positive patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:26:56 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">One additional randomized study (NATO) demonstrated improved disease-free survival for tamoxifen compared to no adjuvant therapy following total mastectomy and axillary dissection in postmenopausal women with axillary node-negative breast cancer. In this study, the benefits of tamoxifen appeared to be independent of estrogen receptor status.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">DOSAGE AND ADMINISTRATION (34068-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:22:10 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Identification of risk factors for bleeding and certain genetic variations in CYP2C9 and VKORC1 in a patient may increase the need for more frequent INR monitoring and the use of lower warfarin doses </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:41:32 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 14:50:56 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:45:02 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Bone Study: Results of a phase 3 safety trial in 262 post menopausal women with resected receptor positive early breast cancer in the adjuvant setting comparing the effect on lumbar spine (L2-L4) bone mineral density (BMD) of adjuvant treatment with letrozole to that with tamoxifen showed at 24 months a median decrease in lumbar spine BMD of 4.1% in the letrozole arm compared to a median increase of 0.3% in the tamoxifen arm (difference = 4.4%) (P&lt;0.0001). No patients with a normal BMD at baseline became osteoporotic over the 2 years and only 1 patient with osteopenia at baseline (T score of -1.9) developed osteoporosis during the treatment period (assessment by central review). The results for total hip BMD were similar, although the differences between the two treatments were less pronounced. During the 2 year period, fractures were reported by 4 of 103 patients (4%) in the letrozole arm, and 6 of 97 patients (6%) in the tamoxifen arm.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ARIPIPRAZOLE-217e52b5-3a7b-4bbe-af3c-b18de7d426c3.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">NEVER restart ZIAGEN or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:20:08 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Citalopram steady state levels were not significantly different in poor metabolizers and extensive metabolizers of CYP2D6.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Aripiprazole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Advise patients that nursing mothers taking codeine can have higher morphine levels in their breast milk if they are ultra-rapid metabolizers. These higher levels of morphine in breast milk may lead to life-threatening or fatal side effects in nursing babies. Advise nursing mothers to watch for signs of morphine toxicity in their infants which includes increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34084-4 ADVERSE REACTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Even at labeled dosage regimens, individuals who are ultra-rapid metabolizers may have life-threatening or fatal respiratory depression or experience signs of overdose (such as extreme sleepiness, confusion, or shallow breathing)</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:11:34 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">An anastrozole adjuvant trial was conducted in 9,366 postmenopausal women with operable breast cancer who were randomized to receive adjuvant treatment with either anastrozole 1 mg daily, tamoxifen 20 mg daily, or a combination of these two treatments for 5 years or until recurrence of the disease. At a median follow-up of 33 months, the combination of anastrozole and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen therapy alone in all patients as well as in the hormone receptor positive subpopulation. This treatment arm was discontinued from the trial.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:56:23 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Deaths have also occurred in nursing infants who were exposed to high levels of morphine in breast milk because their mothers were ultra-rapid metabolizers of codeine </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Change monitoring strategy</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">FIX TABLE</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:38:40 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Did not annotate normal separately in this case.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:57:37 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:37:59 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 15:03:24 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:36:34 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:27:46 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*2, CYP2C9*3</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Some published studies suggest that intermediate metabolizers have decreased active metabolite exposure and diminished antiplatelet effects.\\r\n\\r\nThe relationship between CYP2C19 genotype and clopidogrel bisulfate treatment outcome was evaluated in retrospective analyses of clopidogrel bisulfate-treated subjects in CHARISMA (n=2428) and TRITON-TIMI 38 (n=1477), and in several published cohort studies. In TRITON-TIMI 38 and the majority of the cohort studies, the combined group of patients with either intermediate or poor metabolizer status had a higher rate of cardiovascular events (death, myocardial infarction, and stroke) or stent thrombosis compared to extensive metabolizers. In CHARISMA and one cohort study, the increased event rate was observed only in poor metabolizers.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:43:54 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:09:12 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Required</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:20:01 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Your doctor may do genetic tests to make sure clopidogrel tablets are right for you.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The effect of the scheduled duration of tamoxifen may be described as follows. In women with ER positive or unknown breast cancer receiving 1 year or less, 2 years or about 5 years of tamoxifen, the proportional reductions in mortality were 12%, 17% and 26%, respectively (trend significant at 2p &lt; 0.003). The corresponding reductions in breast cancer recurrence were 21%, 29% and 47% (trend significant at 2p &lt; 0.00001).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">In the NSABP B-09 study in women age 50 to 59 years, only women with both estrogen- and progesterone-receptor levels 10 fmol or greater clearly benefited, while there was a nonstatistically significant trend toward adverse effect in women with both estrogen- and progesterone-receptor levels less than 10 fmol. In women aged 60 to 70 years, there was a trend toward a beneficial effect of tamoxifen without any clear relationship to estrogen- or progesterone-receptor status.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 13:34:44 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43679-0 MECHANISM OF ACTION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34080-2 NURSING MOTHERS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Nursing mothers who are ultra-rapid metabolizers may also experience overdose symptoms such as extreme sleepiness, confusion, or shallow breathing. Prescribers should closely monitor mother-infant pairs and notify treating pediatricians about the use of codeine during breastfeeding</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The patient&#39;s CYP2C9 and VKORC1 genotype information, when available, can assist in selection of the starting dose. Table 5 describes the range of stable maintenance doses observed in multiple patients having different combinations of CYP2C9 and VKORC1 gene variants. Consider these ranges in choosing the initial dose.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43679-0 MECHANISM OF ACTION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">We chose 1 annotation here.

How do we code for dose adjustment is needed? (does this mean time or a catch-all term)</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:27:38 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">No gene symbol for protein S. Add a not there for the future.  Should we just remove this annotation</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Prior to initiating therapy with abacavir, screening for the HLA-B*5701 allele is recommended; this approach has been found to decrease the risk of hypersensitivity reaction. Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-level-high</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-level-low</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">HLA-B*5701-negative patients may develop a hypersensitivity reaction to abacavir; however, this occurs significantly less frequently than in HLA-B*5701-positive patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS (34071-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:30:35 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:52:36 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 13:58:14 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">PATIENT COUNSELING SECTION still not listed.  How do we code advise patients?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:16:25 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MErge with above annoation due to \&quot;rates provided above\&quot;?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:45:02 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">CONTRAINDICATIONS (34070-3)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Drug selection refers to other drugs not drug of interest.  ?  Add Drug selection recommendation or not?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> For patients carrying at least one copy of the CYP2C9*3 allele, the mean daily warfarin dose was 37% less than the mean daily dose for patients homozygous for the CYP2C9*1 allele.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">A meta-analysis of 9 qualified studies including 2775 patients (99% Caucasian) was performed to examine the clinical outcomes associated with CYP2C9 gene variants in warfarin-treated patients.3 In this meta-analysis, 3 studies assessed bleeding risks and 8 studies assessed daily dose requirements. The analysis suggested an increased bleeding risk for patients carrying either the CYP2C9*2 or CYP2C9*3 alleles.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:45:35 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">alleles = multiple copies?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">VKORC1CYP2C9*Ranges are derived from multiple published clinical studies. Other clinical factors (e.g., age, race, body weight, sex, concomitant medications, and comorbidities) are generally accounted for along with genotype in the ranges expressed in the Table. VKORC11639 G(rs9923231) variant is used in this table. Other co-inherited VKORC1 variants may also be important determinants of warfarin dose. Patients with CYP2C9 *1/*3, *2/*2, *2/*3 and *3/*3 may require more prolonged time (&gt;2 to 4 weeks) to achieve maximum INR effect for a given dosage regimen.*1/*1*1/*2*1/*3*2/*2*2/*3*3/*3GG5 to 7 mg5 to 7 mg3 to 4 mg3 to 4 mg3 to 4 mg0.5 to 2 mgAG5 to 7 mg3 to 4 mg3 to 4 mg3 to 4 mg0.5 to 2 mg0.5 to 2 mgAA3 to 4 mg3 to 4 mg0.5 to 2 mg0.5 to 2 mg0.5 to 2 mg0.5 to 2 mg</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:20:44 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:39:24 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT genotyping or phenotyping (red blood cell TPMT activity) can help identify patients who are at an increased risk for developing azathioprine tablets toxicity.2, 3, 7, 8, 9 Accurate phenotyping (red blood cell TPMT activity) results are not possible in patients who have received recent blood transfusions</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Application of HLA-B*1502 genotyping as a screening tool has important limitations and must never substitute for appropriate clinical vigilance and patient management. Many HLA-B*1502-positive Asian patients treated with carbamazepine will not develop SJS/TEN, and these reactions can still occur infrequently in HLA-B*1502-negative patients of any ethnicity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">20 mg/day is the maximum recommended dose for patients who are greater than 60 years of age, patients with hepatic impairment, and for CYP2C19 poor metabolizers or those patients taking cimetidine or another CYP2C19 inhibitor</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Consider alternative treatment or treatment strategies in patients identified as CYP2C19 poor metabolizers</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:54:12 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 16:02:14 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:08:32 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">The search magnifying glass does not work to find this one.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:14:35 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42232-9 PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:35:34 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:47:23 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:01:21 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:02:44 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The most common non-functional alleles associated with reduced levels of TPMT activity are TPMT*2, TPMT*3A and TPMT*3C. Patients with two non-functional alleles (homozygous) have low or absent TPMT activity and those with one non-functional allele (heterozygous) have intermediate activity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">NEVER restart ZIAGEN or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity if receiving conventional doses of azathioprine tablets.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:56:50 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:18:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">HLA-B*5701-negative patients may develop a suspected hypersensitivity reaction to abacavir; however, this occurs significantly less frequently than in HLA-B*5701-positive patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Citalopram steady state levels were not significantly different in poor metabolizers and extensive metabolizers of CYP2D6.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> In women with normal codeine metabolism (normal CYP2D6 activity), the amount of codeine secreted into human milk is low and dose-dependent. However, some women are ultra-rapid metabolizers of codeine. These women achieve higher-than-expected serum levels of codeine’s active metabolite, morphine, leading to higher-than-expected levels of morphine in breast milk and potentially dangerously high serum morphine levels in their breastfed infants. Therefore, maternal use of codeine can potentially lead to serious adverse reactions, including death, in nursing infants.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Screening for carriage of the HLA -B*5701 allele is recommended prior to initiating treatment with abacavir. Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients receiving azathioprine tablets and allopurinol concomitantly should have a dose reduction of azathioprine tablets, to approximately ⅓ to ¼ the usual dose. It is recommended that a further dose reduction or alternative therapies be considered for patients with low or absent TPMT activity receiving azathioprine tablets and allopurinol because both TPMT and XO inactivation pathways are affected</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:55:16 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34090-1 CLINICAL PHARMACOLOGY SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For HLA-B*5701-positive patients, initiating or reinitiating treatment with an abacavir-containing regimen is not recommended and should be considered only with close medical supervision and under exceptional circumstances where potential benefit outweighs the risk.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">UGT1A1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:25:28 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:06:35 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Treatment of breast cancer thought to be hormonally responsive (i.e., estrogen and/or progesterone receptor positive or receptor unknown) has included a variety of efforts to decrease estrogen levels (ovariectomy, adrenalectomy, hypophysectomy) or inhibit estrogen effects (antiestrogens and progestational agents). These interventions lead to decreased tumor mass or delayed progression of tumor growth in some women.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Prior to initiating Carbamazepine Extended-Release Capsule therapy, testing for HLA-B*1502 should be performed in patients with ancestry in populations in which HLA-B*1502 may be present. In deciding which patients to screen, the rates provided above for the prevalence of HLA-B*1502 may offer a rough guide, keeping in mind the limitations of these figures due to wide variability in rates even within ethnic groups, the difficulty in ascertaining ethnic ancestry, and the likelihood of mixed ancestry.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Tests are available to identify a patient&#39;s CYP2C19 genotype; these tests can be used as an aid in determining therapeutic strategy</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> In 201 Caucasian patients treated with stable warfarin doses, genetic variations in the VKORC1 gene were associated with lower warfarin doses. In this study, about 30% of the variance in warfarin dose could be attributed to variations in the VKORC1 gene alone; about 40% of the variance in warfarin dose could be attributed to variations in VKORC1 and CYP2C9 genes combined.5 About 55% of the variability in warfarin dose could be explained by the combination of VKORC1 and CYP2C9 genotypes, age, height, body weight, interacting drugs, and indication for warfarin therapy in Caucasian patients.5 Similar observations have been reported in Asian patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add test result</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:49:25 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Even in the absence of the HLA-B*5701 allele, it is important to permanently discontinue abacavir and not rechallenge with abacavir if a hypersensitivity reaction cannot be ruled out on clinical grounds, due to the potential for a severe or even fatal reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Change monitoring strategy</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Alternative Recommended</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*2, CYP2C9*3</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Use specific</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 13:45:50 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">THIS ONE IS BROKEN, LOCATION OF ANNOTATION IS APPLIED TO IS INCORRECT.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Prior to initiating therapy with abacavir, screening for the HLA-B*5701 allele is recommended; this approach has been found to decrease the risk of a hypersensitivity reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:54:57 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:00:00 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9CA1FBF8-5D9F-4C89-9F89-2BC4E3DB1BF5"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Certain single nucleotide polymorphisms in the VKORC1 gene (especially the -1639G&gt;A allele) have been associated with lower dose requirements for warfarin. In 201 Caucasian patients treated with stable warfarin doses, genetic variations in the VKORC1 gene were associated with lower warfarin doses. In this study, about 30% of the variance in warfarin dose could be attributed to variations in the VKORC1 gene alone; about 40% of the variance in warfarin dose could be attributed to variations in VKORC1 and CYP2C9 genes combined.5 About 55% of the variability in warfarin dose could be explained by the combination of VKORC1 and CYP2C9 genotypes, age, height, body weight, interacting drugs, and indication for warfarin therapy in Caucasian patients.5 Similar observations have been reported in Asian patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">how do we code \\\\\\\&quot;tell your doctor\\\\\\\&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:08:25 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:07:12 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:25:13 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:43:59 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-SNP-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:23:21 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:21:06 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:35:09 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:00:21 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 08:55:42 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Clopidogrel tablets may not work as well in people who:\\r\n\\r\n    have certain genetic factors that affect how the body breaks down clopidogrel tablets.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The patient&#39;s CYP2C9 and VKORC1 genotype information, when available, can assist in selection of the starting dose. Table 5 describes the range of stable maintenance doses observed in multiple patients having different combinations of CYP2C9 and VKORC1 gene variants. Consider these ranges in choosing the initial dose.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Respiratory depression and death have occurred in children who received codeine in the post-operative period following tonsillectomy and/or adenoidectomy and had evidence of being ultra-rapid metabolizers of codeine (i.e., multiple copies of the gene for cytochrome P450 isoenzyme 2D6 [CYP2D6] or high morphine concentrations)</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:38:07 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:22:29 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT activity is controlled by a genetic polymorphism.1, 2, 3 For Caucasians and African Americans, approximately 10% of the population inherit one non-functional TPMT allele (heterozygous) conferring intermediate TPMT activity, and 0.3% inherit two TPMT non-functional alleles (homozygous) for low or absent TPMT activity. Non-functional alleles are less common in Asians. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:34:06 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT genotyping or phenotyping can help identify patients who are at an increased risk for developing azathioprine toxicity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34067-9 INDICATIONS AND USAGE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add drug selection recommendation of &quot;indicated for&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:22:39 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:51:53 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:01:41 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Based on this study, it is estimated that 61% of patients with the HLA-B*5701 allele will develop a clinically suspected hypersensitivity reaction during the course of abacavir treatment compared with 4% of patients who do not have the HLA-B*5701 allele.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:20:40 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">UGT1A1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 16:03:11 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:28:34 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:51:09 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:21:52 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Did not say provided specific dose recommendations.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Among women with ER positive or unknown breast cancer and positive nodes who received about 5 years of treatment, overall survival at 10 years was 61.4% for tamoxifen vs. 50.5% for control (logrank 2p &lt; 0.00001). The recurrence-free rate at 10 years was 59.7% for tamoxifen vs. 44.5% for control (logrank 2p &lt; 0.00001). Among women with ER positive or unknown breast cancer and negative nodes who received about 5 years of treatment, overall survival at 10 years was 78.9% for tamoxifen vs. 73.3% for control (logrank 2p &lt; 0.00001). The recurrence-free rate at 10 years was 79.2% for tamoxifen vs. 64.3% for control (logrank 2p &lt; 0.00001).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">FIX TABLE</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:40:26 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42232-9 PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Letrozole tablets was initially studied at doses of 0.1 mg to 5.0 mg daily in six non-comparative Phase I/II trials in 181 postmenopausal estrogen/progesterone receptor positive or unknown advanced breast cancer patients previously treated with at least antiestrogen therapy. Patients had received other hormonal therapies and also may have received cytotoxic therapy. Eight (20%) of forty patients treated with letrozole tablets 2.5 mg daily in Phase I/II trials achieved an objective tumor response (complete or partial response).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">CNA106030 (PREDICT-1), a randomized, double-blind study, evaluated the clinical utility of prospective HLA-B*5701 screening on the incidence of abacavir hypersensitivity reaction in abacavir-naive HIV-1-infected adults (n = 1,650). In this study, use of pre-therapy screening for the HLA-B*5701 allele and exclusion of subjects with this allele reduced the incidence of clinically suspected abacavir hypersensitivity reactions from 7.8% (66/847) to 3.4% (27/803).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients with intermediate TPMT activity may be at increased risk of myelotoxicity if receiving conventional doses of azathioprine tablets.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:11:19 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D50A614-4F2B-42C6-A175-0BF3C158B5DA"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Clopidogrel is a prodrug. Inhibition of platelet aggregation by clopidogrel is achieved through an active metabolite. The metabolism of clopidogrel to its active metabolite can be impaired by genetic variations in CYP2C19 [see Boxed Warning] and by concomitant medications that interfere with CYP2C19.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:20:04 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:903F27DB-914A-44A2-B01F-A36164AAC4DB"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For HLA-B*5701-positive patients, treatment with an abacavir-containing regimen is not recommended and should be considered only with close medical supervision and under exceptional circumstances when the potential benefit outweighs the risk.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity if receiving conventional doses of azathioprine.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">multiple copies of the gene for cytochrome P450 isoenzyme 2D6 [CYP2D6] </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:17:54 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34090-1 CLINICAL PHARMACOLOGY SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:02:38 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34073-7 DRUG INTERACTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">multiple copies of gene in allele section?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">In a small substudy (N = 81) of the NSABP P-1 trial, there appeared to be no benefit to screening women for Factor V Leiden and Prothrombin mutations G20210A as a means to identify those who may not be appropriate candidates for tamoxifen therapy.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:16:47 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:02:40 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:29:03 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 15:01:13 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:78CB3193-D01C-49AA-B39B-C35887919EED"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:14:50 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">HLA-B*5701-negative patients may develop a hypersensitivity reaction to abacavir; however, this occurs significantly less frequently than in HLA-B*5701-positive patients.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 15:33:19 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add new test result.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:18:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">CLINICAL STUDIES (34092-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The dose of warfarin sodium tablets must be individualized by monitoring the PT/INR. Not all factors causing warfarin dose variability are known. The maintenance dose needed to achieve a target PT/INR is influenced by:\n●\n     Clinical factors including age, race, body weight, sex, concomitant medications, and comorbidities and\n●\n     Genetic factors (CYP2C9 and VKORC1 genotypes).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Alternative Recommended</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 13:50:32 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Before starting ZIAGEN, tell your doctor about all of your medical conditions, including if you:\nhave been tested and know whether or not you have a particular gene variation called HLA-B*5701.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Alternative Recommended</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">add to drop down; alleles necessary?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:04:12 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:04:12 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:36:03 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Need an option for discontinue</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">NSABP B-14, a prospective, double-blind, randomized study, compared tamoxifen to placebo in women with axillary node-negative, estrogen receptor positive (≥ 10 fmol/mg cytosol protein) breast cancer (as adjuvant therapy, following total mastectomy and axillary dissection, or segmental resection, axillary dissection, and breast radiation). After 5 years of treatment, there was a significant improvement in disease-free survival in women receiving tamoxifen. This benefit was apparent both in women under age 50 and in women at or beyond age 50.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> NEVER restart ZIAGEN or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients who carry the HLA-B*5701 allele are at high risk for experiencing a hypersensitivity reaction to abacavir. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:9179</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">add drop down choice to tests</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:46A370D2-9D5B-4964-96D7-FECDB2FC0ED4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For genetically at-risk patients [See WARNINGS], high-resolution &#39;HLA-B*1502 typing&#39; is recommended. The test is positive if either one or two HLA-B*1502 alleles are detected and negative if no HLA-B*1502 alleles are detected.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:720F1FAF-C317-4375-8323-04DFEE0FAAFE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">VKORC1CYP2C9*Ranges are derived from multiple published clinical studies. Other clinical factors (e.g., age, race, body weight, sex, concomitant medications, and comorbidities) are generally accounted for along with genotype in the ranges expressed in the Table. VKORC11639 G(rs9923231) variant is used in this table. Other co-inherited VKORC1 variants may also be important determinants of warfarin dose. Patients with CYP2C9 *1/*3, *2/*2, *2/*3 and *3/*3 may require more prolonged time (&gt;2 to 4 weeks) to achieve maximum INR effect for a given dosage regimen.*1/*1*1/*2*1/*3*2/*2*2/*3*3/*3GG5 to 7 mg5 to 7 mg3 to 4 mg3 to 4 mg3 to 4 mg0.5 to 2 mgAG5 to 7 mg3 to 4 mg3 to 4 mg3 to 4 mg0.5 to 2 mg0.5 to 2 mgAA3 to 4 mg3 to 4 mg0.5 to 2 mg0.5 to 2 mg0.5 to 2 mg0.5 to 2 mg</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For HLA-B*5701-positive patients, treatment with an abacavir-containing regimen is not recommended and should be considered only with close medical supervision and under exceptional circumstances when the potential benefit outweighs the risk.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:05:18 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For HLA-B*5701-positive patients, initiating or reinitiating treatment with an abacavir-containing regimen is not recommended and should be considered only with close medical supervision and under exceptional circumstances where potential benefit outweighs the risk.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">PATIENT COUNSELING SECTION still not listed.  How do we code advise patients?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Studies have shown that carriage of the HLA-B*5701 allele is associated with a significantly increased risk of a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*2, CYP2C9*3</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:30:56 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:27:38 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Numerous factors, alone or in combination, including changes in diet, medications, botanicals and genetic variations in the CYP2C9 and VKORC1 enzymes (seeCLINICAL PHARMACOLOGY,Pharmacogenomics) may influence the response of the patient to warfarin.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Even in the absence of the HLA-B*5701 allele, it is important to permanently discontinue abacavir and not rechallenge with abacavir if a hypersensitivity reaction cannot be ruled out on clinical grounds, due to the potential for a severe or even fatal reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">A crossover study in 40 healthy subjects, 10 each in the four CYP2C19 metabolizer groups, evaluated pharmacokinetic and antiplatelet responses using 300 mg followed by 75 mg per day and 600 mg followed by 150 mg per day, each for a total of 5 days. Decreased active metabolite exposure and diminished inhibition of platelet aggregation were observed in the poor metabolizers as compared to the other groups. When poor metabolizers received the 600 mg/150 mg regimen, active metabolite exposure and antiplatelet response were greater than with the 300 mg/75 mg regimen (see Table 3). An appropriate dose regimen for this patient population has not been established in clinical outcome trials.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">how to annotation increased effect with increased duration of therapy (PD?)</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*1/*1, CYP2C9*1/*2, CYP2C9*1/*3, CYP2C9*2/*2, CYP2C9*2/*3, CYP2C9*3/*3, CYP2C9*5, CYP2C9*6, CYP2C9*11, CYP2C9*9</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34070-3 CONTRAINDICATIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE154A72-C1D3-4027-8C73-C71A948D0F52"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">CNA106030 (PREDICT-1), a randomized, double-blind study, evaluated the clinical utility of prospective HLA-B*5701 screening on the incidence of abacavir hypersensitivity reaction in abacavir-naive HIV-1-infected adults (n = 1,650). In this study, use of pre-therapy screening for the HLA-B*5701 allele and exclusion of subjects with this allele reduced the incidence of clinically suspected abacavir hypersensitivity reactions from 7.8% (66/847) to 3.4% (27/803). Based on this study, it is estimated that 61% of patients with the HLA-B*5701 allele will develop a clinically suspected hypersensitivity reaction during the course of abacavir treatment compared with 4% of patients who do not have the HLA-B*5701 allele.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Excretion Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:22:51 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT TESTING CANNOT SUBSTITUTE FOR COMPLETE BLOOD COUNT (CBC) MONITORING IN PATIENTS RECEIVING AZATHIOPRINE TABLETS. TPMT genotyping or phenotyping can be used to identify patients with absent or reduced TPMT activity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">did not use low or absent phenotype as these terms are not used with this drug.  It&#39;s all poor metabolizer for CYPs</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C19*1 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C9CADF5C-CD94-4A8C-B6CF-12220ED65397"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:30:00 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT activity is controlled by a genetic polymorphism.1, 2, 3 For Caucasians and African Americans, approximately 10% of the population inherit one non-functional TPMT allele (heterozygous) conferring intermediate TPMT activity, and 0.3% inherit two TPMT non-functional alleles (homozygous) for low or absent TPMT activity. Non-functional alleles are less common in Asians. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The CYP2C19*1 allele corresponds to fully functional metabolism while the CYP2C19*2 and *3 alleles are nonfunctional. CYP2C19*2 and *3 account for the majority of reduced function alleles in white (85%) and Asian (99%) poor metabolizers. Other alleles associated with absent or reduced metabolism are less frequent, and include, but are not limited to, CYP2C19*4, *5, *6, *7, and *8. A patient with poor metabolizer status will possess two loss-of-function alleles as defined above. Published frequencies for poor CYP2C19 metabolizer genotypes are approximately 2% for whites, 4% for blacks and 14% for Chinese.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34090-1 CLINICAL PHARMACOLOGY SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:194FD718-B3CA-4D25-B3D2-56D36C1ECB60"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98FB995B-3B3B-4C86-ACA3-EE4F9F310F41"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity from azathioprine tablets if conventional doses are given. Physicians may consider alternative therapies for patients who have low or absent TPMT activity (homozygous for non-functional alleles).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">mixing terminology... positive and high/low for biomarker test results</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not start</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients taking ZIAGEN may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of this allergic reaction is much higher if you have a gene variation called HLA-B*5701 than if you do not. Your doctor can determine with a blood test if you have this gene variation.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Screening for carriage of the HLA -B*5701 allele is recommended prior to initiating treatment with abacavir. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:05:25 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Tests are available to determine a patient’s CYP2C19 genotype.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:29:04 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34070-3 CONTRAINDICATIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:06:13 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">multiple copies of the gene for cytochrome P450 isoenzyme 2D6</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:59:09 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34084-4 ADVERSE REACTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:18:20 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:01:09 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> In a small substudy (N = 81) of the NSABP P-1 trial, there appeared to be no benefit to screening women for Factor V Leiden and Prothrombin mutations G20210A as a means to identify those who may not be appropriate candidates for tamoxifen therapy.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:07:26 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:31:28 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">It is recommended that consideration be given to either genotype or phenotype patients for TPMT. Phenotyping and genotyping methods are commercially available.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:24:52 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34090-1 CLINICAL PHARMACOLOGY SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Benefit is less clear for women with ER poor breast cancer in whom the proportional reduction in recurrence was 10% (2p = 0.007) for all durations taken together, or 9% (2p = 0.02) if contralateral breast cancers are excluded. The corresponding reduction in mortality was 6% (NS).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Poor metabolizers with acute coronary syndrome or undergoing percutaneous coronary intervention treated with clopidogrel bisulfate at recommended doses exhibit higher cardiovascular event rates than do patients with normal CYP2C19 function.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:24:05 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B39F957-E88F-427C-AC41-F1B9DC711A02"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">include test results in dropdown</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:17:29 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:22:01 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42229-5 SPL UNCLASSIFIED SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:24:15 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">VKORC1-1639G&gt;A</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:25:51 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">extensive-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:AF427FC6-54B8-4CA4-9C51-233E64726500"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:35:15 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Patients carrying at least one copy of the CYP2C9*2 allele required a mean daily warfarin dose that was 17% less than the mean daily dose for patients homozygous for the CYP2C9*1 allele</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:09:39 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not necessary</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1F72593-1500-4B06-AE14-AE29B3EAE9B1"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Consider alternative treatment or treatment strategies in patients identified as CYP2C19 poor metabolizers.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Hereditary or acquired deficiencies of protein C or its cofactor, protein S, have been associated with tissue necrosis following warfarin administration. Not all patients with these conditions develop necrosis, and tissue necrosis occurs in patients without these deficiencies.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/TAMOXIFEN-7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:91050818-2692-4B82-B3D8-A52A364F00D7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2F3B0124-31A3-451B-BA81-5652303A452C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB17C9EA-111C-4784-80AC-30417D974CE8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Citalopram 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:94F5EFA2-DEF5-444E-B4C2-7268B36AF650"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:36D17D73-1169-4131-94F5-24AFD369088A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">If the patient is of unknown HLA-B*5701 status, screening for the allele is recommended prior to reinitiation of ZIAGEN.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A5666BB-F43D-45F3-A856-0BDB0E745589"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Azathioprine tablets should be administered with caution to patients having one non-functional allele (heterozygous) who are at risk for reduced TPMT activity that may lead to toxicity if conventional doses are given. Dosage reduction is recommended in patients with reduced TPMT activity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6D4DAD4D-1B63-4482-8060-787D97F917D2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A8189564-74C8-463F-9927-917478975C75"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The effectiveness of clopidogrel bisulfate is dependent on its activation to an active metabolite by the cytochrome P450 (CYP) system, principally CYP2C19 [see Warnings and Precautions (5.1)]. Clopidogrel bisulfate at recommended doses forms less of that metabolite and has a smaller effect on platelet function in patients who are CYP2C19 poor metabolizers</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A45211F-B49B-48F5-A9B9-D593DF301DA5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:405A5AAA-08FD-470C-9B50-67E44ED1462F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:27:23 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AC31138E-D96E-46FA-AD16-E8C5C6855989"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The most common non-functional alleles associated with reduced levels of TPMT activity are TPMT*2, TPMT*3A and TPMT*3C. Patients with two non-functional alleles (homozygous) have low or absent TPMT activity and those with one non-functional allele (heterozygous) have intermediate activity.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:14BA7077-8D33-42DD-A380-DD27F50087AD"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">to generic for allele vs leaving phenotype on its own?</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:217B566B-E501-4A3D-A7B5-BFA5CE66147B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DB8F110F-7415-4B13-AB5B-23F1D7A1C6BF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">n an observational study, the risk of achieving INR &gt;3 during the first 3 weeks of warfarin therapy was determined in 219 Swedish patients retrospectively grouped by CYP2C9 genotype. The relative risk of over anticoagulation as measured by INR &gt;3 during the first 2 weeks of therapy was approximately doubled for those patients classified as *2 or *3 compared to patients who were homozygous for the *1 allele.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:14:34 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:43:27 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-23 14:34:14 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF1A2A13-1CD9-47EC-A75C-192353959653"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Advise patients that some people have a genetic variation that results in codeine changing into morphine more rapidly and completely than other people. Most people are unaware of whether they are an ultra-rapid codeine metabolizer or not. These higher-than-normal levels of morphine in the blood may lead to life-threatening or fatal respiratory depression or signs of overdose such as extreme sleepiness, confusion, or shallow breathing. Children with this genetic variation who were prescribed codeine after tonsillectomy and/or adenoidectomy for obstructive sleep apnea may be at greatest risk based on reports of several deaths in this population due to respiratory depression.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Use specific</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Hereditary or acquired deficiencies of protein C or its cofactor, protein S, have been associated with tissue necrosis following warfarin administration. Not all patients with these conditions develop necrosis, and tissue necrosis occurs in patients without these deficiencies.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The estrogen- and progesterone-receptor values may help to predict whether adjuvant tamoxifen citrate tablet therapy is likely to be beneficial.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B7239DA-6BB5-450F-B107-37E66914C66D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:65BD7CC9-2CFA-43C3-A5F0-FBC0221449BF"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:ConcomitantMedicationOfConcern xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Concomitant medication concern</n0pred:ConcomitantMedicationOfConcern></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">POLG</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8525CDF6-1EFA-4AA5-BD43-C9DDE92E0196"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F7D9EE5F-E5C0-4296-9825-534C2F768855"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">\nRisk of death in ultra-rapid metabolizers: Conversion of codeine into its active metabolite, morphine, may occur more rapidly and completely resulting in higher than expected morphine levels and respiratory depression or death. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA417E62-D7D9-4F45-8359-10CCF8D13F90"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:21:03 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E003EB3-2B97-41C7-BD14-5EAF744BB5F2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A74CD0BB-2B56-45FC-B50D-C7952B9C9AE4"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9DDE5A30-59ED-49D7-B9B6-316245562477"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">CYP2C9 GenotypeNS-Warfarin Clearance/Lean Body Weight(mL/min/kg)Mean (SD)**SD=standard deviation.p&lt;0.001. Pairwise comparisons indicated significant differences among all 3 genotypes.*1/*11180.065 (0.025)*1/*2 or*1/*3590.041 (0.021)*2/*2, *2/*3or *3/*3110.020 (0.011)Total188Other CYP2C9 alleles associated with reduced enzymatic activity occur at lower frequencies, including *5, *6, and *11 alleles in populations of African ancestry and *5, *9 and *11 alleles in Caucasians.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">No gene symbol for protein C (PROC) and protein S.  Add a not there for the future.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55BCCCDC-ED3F-427D-AFFE-0E80E459C63A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AAB53C8F-FB14-4216-82D9-D7CD0AB15000"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Respiratory depression and death have occurred in children with obstructive sleep apnea who received codeine in the post-operative period following tonsillectomy and/or adenoidectomy and had evidence of being ultra-rapid metabolizers of codeine (i.e., multiple copies of the gene for cytochrome P450 isoenzyme 2D6 or high morphine concentrations). These children may be particularly sensitive to the respiratory depressant effects of codeine that has been rapidly metabolized to morphine.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42231-1 SPL MEDGUIDE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34080-2 NURSING MOTHERS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DCF9A15D-3781-426E-B12E-C37A11772BAD"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add drug selection recommendation of &quot;indicated for&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:232C5C6E-F6FE-44B8-AE5A-7E1BD427D626"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34075-2 LABORATORY TESTS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3B78E07-8B27-4774-B221-CC47DAC8365E"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FDE7EC5-68D1-4D11-A164-0B2DA9D73292"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:19:11 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55700EE9-88B8-49B7-BD64-1A87D99DCC15"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C24DFA02-2096-4634-974B-1866183BFD0B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">add intermediate to dropdown</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B036858-70F5-4077-8333-F34F19A042EC"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:30:33 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:563CB9E8-A4E7-43EF-9686-1F5B71F4169D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5EE59E00-2977-4F09-A933-867C3E165210"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">how do we code \\\\\\\&quot;tell your doctor\\\\\\\&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:70BE7DEB-6A8B-41E9-9333-F1F47AC7E1A0"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42232-9 PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5B3334-40F5-4B23-8773-AFED2978DC1D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:04:16 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:09:18 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D8A9803-9C09-4301-8254-AF8BCE7E83F8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:9179</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90768224-544A-41CF-9969-E08884F1434D"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10FC0DB-5D49-46E9-A2C2-3CFFC5FBF692"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:239D0F43-DA9B-4ED8-A683-6BF29DB82241"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:408C86B9-FFBA-4A7F-A6EC-ECD348FD4782"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3535</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7D37999E-F183-41DD-8FEF-19696FD23D30"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:64BC1D21-CAE1-4F85-A596-73342A9D5388"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:44BBF444-A1D4-4182-8B05-775BFFCA0DF4"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:240C39EC-A129-42D3-8602-5C743EC412D2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The Early Breast Cancer Trialists&#39; Collaborative Group (EBCTCG) conducted worldwide overviews of systemic adjuvant therapy for early breast cancer in 1985, 1990, and again in 1995. In 1998, 10 year outcome data were reported for 36,689 women in 55 randomized trials of adjuvant tamoxifen using doses of 20 to 40 mg/day for 1 to 5+ years. Twenty-five percent of patients received one year or less of trial treatment, 52% received 2 years, and 23% received about 5 years. Forty-eight percent of tumors were estrogen receptor (ER) positive (&gt; 10 fmol/mg), 21% were ER poor (&lt; 10 fmol/l), and 31% were ER unknown. Among 29,441 patients with ER positive or unknown breast cancer, 58% were entered into trials comparing tamoxifen to no adjuvant therapy and 42% were entered into trials comparing tamoxifen in combination with chemotherapy vs. the same chemotherapy alone.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5CCA20AA-4D3C-40F4-BAED-C832E665FA35"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">66106-6 PHARMACOGENOMICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CDE45635-21AB-4AC7-89FF-C772F3A15A2C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">POLG</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5464F1B8-CF3D-4DA9-99F4-5F156C14CE70"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1042FEEA-5AF3-4E50-B2A1-053451F2236C"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:942AE26F-116C-4165-9118-723E840DFB17"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29B0BAC9-227E-4C4D-96D2-143CC457E50C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9098E55C-952E-46DF-904C-2A3E63492B3A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B74A738-1124-4DAC-BE25-F15C78CFBA15"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3665D7A9-FCD1-4278-8B7F-5EA5B3CC19D3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F19D3DA9-E091-415D-A43E-483BEC7B68FB"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C692DA9C-1ECF-4A5B-867C-ABAF23492F10"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add test result</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E02315A-EB6D-4693-B3E4-4FB4B99D4253"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">PATIENT MEDICATION INFORMATION (68498-5)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34090-1 CLINICAL PHARMACOLOGY SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Identification of risk factors for bleeding and certain genetic variations in CYP2C9 and VKORC1 in a patient may increase the need for more frequent INR monitoring and the use of lower warfarin doses </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 13:44:33 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0F8A06DC-D6FE-466C-AF73-CF9E7A8C2707"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017048</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F777C391-7D5E-4F49-948B-5B9ACB2587FA"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F10DDB11-A5F0-4B5E-B3CE-47B1F2145E34"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FE73DA30-2D2E-4D34-AC2F-B160599E5ADD"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-level-low</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EF161740-C79C-4D2A-9002-4B0A139BF81E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE4F247F-F7CB-4776-A379-05B0401FC08D"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:028082D6-59BF-44E8-9117-CC155DA8D008"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:12:22 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86218E9C-9C50-4CF1-BDF5-7480485335DE"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not Important</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Use specific</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4EEB4B8C-B4AE-42C6-9E9C-805907F3A548"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34067-9 INDICATIONS AND USAGE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Lipid Study: In a phase 3 safety trial in 262 post menopausal women with resected receptor positive early breast cancer at 24 months comparing the effects on lipid profiles of adjuvant letrozole to tamoxifen, 12% of patients on letrozole had at least one total cholesterol value of a higher CTCAE grade than at baseline compared with 4% of patients on tamoxifen.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79C530FF-637A-43C8-AECE-CA81458FB5EE"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The HLA-B*1502 allele has not been found to predict risk of less severe adverse cutaneous reactions from carbamazepine, such as anticonvulsant hypersensitivity syndrome or non-serious rash (maculopapular eruption [MPE])</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2D6*1/*1xN, CYP2D6*1/*2xN</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74791FAB-E4B4-4EA3-9557-BD68EDB49B01"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F30A3592-1EDA-414B-8C7B-2B931B766619"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:56ECCD1C-D5DA-4A5F-A470-A96F404E1CB8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:38:14 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:51CDF79D-8F09-44DB-AE3B-91C93D13095C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E1788A3-66E3-4952-B193-2C5E9B1AB551"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0C42BD-3C98-4864-9F9C-50F72712CEC9"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3419ECAE-A4FF-4BE4-8679-16B52BA748AC"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55ED86AA-B414-4220-94FD-868AFE2D1278"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:03:17 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE5D6919-6972-4689-B658-C5432A02F905"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1B1E4FE2-11FA-4FB0-85F2-014750705FED"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not start</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE3C3FF6-F83D-47D2-8C4F-944687265F2B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D888391C-2CE3-4955-850C-C8FA6291737A"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0E7639-6AE6-4519-9A14-41BF8AB6A508"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Doesn&#39;t really say decreased metabolism for PK outcome, it says increased levels or exposure, but not a choice.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C8824A36-9C96-4389-B215-2638B48B5437"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Codeine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ED2F98CA-60F0-4D49-9803-FED968AA3114"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e143044e90f26014518a19cf70063</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Accurate phenotyping (red blood cell TPMT activity) results are not possible in patients who have received recent blood transfusions. TPMT testing may also be considered in patients with abnormal CBC results that do not respond to dose reduction. Early drug discontinuation in these patients is advisable. TPMT TESTING CANNOT SUBSTITUTE FOR COMPLETE BLOOD COUNT (CBC) MONITORING IN PATIENTS RECEIVING AZATHIOPRINE TABLETS</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:86480047-DD43-4A54-B258-3772C18237F7"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">TPMT genotyping or phenotyping can help identify patients with low or absent TPMT activity (homozygous for non-functional alleles) who are at increased risk for severe, life-threatening myelosuppression from azathioprine tablets (see CLINICAL PHARMACOLOGY, WARNINGSand PRECAUTIONS: Laboratory Tests). Death associated with pancytopenia has been reported in patients with absent TPMT activity receiving azathioprine.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55F59962-81BB-4F69-B3DD-6B65B3526228"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87228117-6F6A-41A0-9709-5D0977E83A06"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34067-9 INDICATIONS AND USAGE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:75A79304-2BD1-4F33-9391-4BB93929D4E6"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:22:05 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add drug selection recommendation of &quot;indicated for&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:55544593-2536-44D4-B561-50DB89250F52"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E014618E-3373-4F61-BAF6-4ABD45885081"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1F2D1F90-DA97-42FE-836C-EBF3BAC56349"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1706E63C-45AC-467E-80FD-06108C69A93D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">F2</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:20FD83E0-8F9F-409B-BA60-7D4A2F8A54AF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Poor metabolizers treated with clopidogrel bisulfate at recommended doses exhibit higher cardiovascular event rates following acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) than patients with normal CYP2C19 function.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:54:36 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC0A4D53-4B45-488A-8775-B46BF1E9B010"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:19:32 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BC59C368-6171-459A-BA88-9B57AAC67FD8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0F7787E-5F9C-47A4-86B2-D64F1B7602B6"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*2 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER and PgR_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C6988919-6455-4291-92FF-E4F63DF9F9BF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:037A2873-CACE-474F-B3EB-1EF6E0A58FCF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> If the patient is of unknown HLA-B*5701 status, screening for the allele is recommended prior to reinitiation of ZIAGEN.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A6AED276-0422-482B-8802-87BDABE2C035"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Tamoxifen citrate tablets are a prescription medicine that is like estrogen (female hormone) in some ways and different in other ways. In the breast, tamoxifen can block estrogen&#39;s effects. Because it does this, tamoxifen may block the growth of breast cancers that need estrogen to grow (cancers that are estrogen- or progesterone-receptor positive).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:31:59 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:61B14255-647D-4AA2-83E5-B81256BF7A50"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1924E2D5-9E52-46A8-925D-043869F8F777"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6347DAEC-6E58-45D7-9A9D-16BE602F4930"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:51:08 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D988CE-7527-421D-AAA6-0C9C0D4B30DF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1199968-6650-4D2A-A5E4-EDFBFE7733AE"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The maximum dose should be limited to 20 mg/day in patients who are CYP2C19 poor metabolizers or those patients who may be taking concomitant cimetidine or another CYP2C19 inhibitor, since higher citalopram exposures would be expected.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4019443F-CB02-40D7-BB18-37DDB00B1548"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C843591-806D-42E0-88A9-58DC59076B3D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:945EB72E-5C75-41B0-B8FC-637E1EF0AE7D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E1E45497-D882-456B-B573-7A640A307AFB"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:34:27 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:15:46 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B4BE2A8-5AB2-47D3-A46D-2D1D5E7AC42F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">CYP2C9*3</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000017303</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-level-low</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:55709DA6-0396-4327-B704-FE38E5F01C43"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:CFEF239C-B763-4864-8DD8-A917EFD12673"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72569EC5-72D5-43F3-9028-CE31C726B1D0"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C97CADE4-3861-4CB6-A21E-09BF0AEB1F88"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 08:59:45 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:45844BA9-29ED-4EC6-94C0-81C9883F880F"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C427075F-5339-47EB-A313-AA6B94EB8753"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:41CC62A5-5C3A-449F-B7A3-675F76FA4085"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7BFF4A61-D45D-4C1F-9599-BD435EF039B8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34071-1 WARNINGS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5BA0362C-1EF8-4647-8A30-017F5378F48F"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">TPMT*2, TPMT*3A, TPMT*3C</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3467</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:98226070-C5AF-407A-B6D1-D521CD001163"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F3C6E27C-CBBA-4B36-810C-D42C3FA4AB93"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74B97B42-8CF1-41BB-84AD-CF0995E7508C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1BEAB346-F7B3-40D8-AE65-17ACEB48A7A4"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:CF0F356A-4BD3-4AB3-80E4-DF7EF3CD5F00"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:47718F61-F7FA-4A83-BB17-C13189D5E884"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34067-9 INDICATIONS AND USAGE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E6578AA5-3295-46D7-B3F2-55CD3CFB5B0F"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C37B19E6-A2FE-4CF4-9914-61A4EF8E7827"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:86565D69-8F9C-4519-9A52-CD2A2980DEE3"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D9543430-9668-4C09-8709-B8D20B095EEA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9992ADBC-4BAB-4529-BAC4-9D7AFD34F098"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><n0pred:createdBy xmlns:n0pred="http://purl.org/pav/">urn:person:uuid:080e14304488c4b70144896f4a03000b</n0pred:createdBy></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F1D12488-2CA1-4EAD-9A8A-C92106847342"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The relationship between CYP2C19 genotype and clopidogrel bisulfate treatment outcome was evaluated in retrospective analyses of clopidogrel bisulfate-treated subjects in CHARISMA (n=2428) and TRITON-TIMI 38 (n=1477), and in several published cohort studies. In TRITON-TIMI 38 and the majority of the cohort studies, the combined group of patients with either intermediate or poor metabolizer status had a higher rate of cardiovascular events (death, myocardial infarction, and stroke) or stent thrombosis compared to extensive metabolizers. In CHARISMA and one cohort study, the increased event rate was observed only in poor metabolizers.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0F7B1E31-9D8A-45AA-8F34-A942EE6FBB80"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:23663</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:14099187-A7EA-4F77-905D-B1B942FF80D7"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Prior to initiating therapy with abacavir, screening for the HLA-B*5701 allele is recommended; this approach has been found to decrease the risk of hypersensitivity reaction.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1D33EB0C-A03D-481F-991D-B71848865C38"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:09730EE5-3645-4E22-8362-E17C60539840"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E8587041-73D9-4727-A9F5-7445BAF204E3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">intermediate-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:237CBF43-3113-4746-AC7C-0EEE2CD7D926"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F270E3B3-9983-425D-98FB-66F62E36340F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8A35BACC-77B7-4822-A677-4D72A3B91942"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CODEINE-fa3ed180-298a-4f9d-9d05-15182d7218bf.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:C7EAEB14-8213-4EF8-AC67-469D0609826B"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE2D417D-24B3-4A7E-BE0B-FBF0E34B509B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Take note that tests are avaliable</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9EBC36A6-A85E-4348-8EBC-5B071D8A79FB"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:49:18 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:EBA440A2-4EF9-40CD-89BF-56AB858385E6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:10:26 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients with intermediate thiopurine S-methyl transferase (TPMT) activity may be at an increased risk of myelotoxicity if receiving conventional doses of azathioprine.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:97CDCA51-103C-4EB7-BA80-9670B117D103"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:108444AC-C8D7-42EE-A011-BE98A3F592F0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B752346E-6167-497D-B585-83983FA71DA2"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:21B282F1-F0CA-488A-B703-88611F099D16"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:96D6F8F1-F51A-4EBC-BFF7-C799690B4401"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decreased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9D01B1F5-3775-4CA3-BDFA-97BF6089AE2E"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Risk Factor: HLA-B*5701 Allele: Studies have shown that carriage of the HLA-B*5701 allele is associated with a significantly increased risk of a hypersensitivity reaction to abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">BOXED WARNING (34066-1)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34084-4 ADVERSE REACTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCAE5E0C-30F2-4E8B-8D8E-687ADD4CA18B"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Some individuals may be ultra-rapid metabolizers because of a specific CYP2D6 genotype (gene duplications denoted as *1/*1xN or *1/*2xN). The prevalence of this CYP2D6 phenotype varies widely and has been estimated at 0.5 to 1% in Chinese and Japanese, 0.5 to 1% in Hispanics, 1 to 10% in Caucasians, 3% in African Americans, and 16 to 28% in North Africans, Ethiopians, and Arabs. Data are not available for other ethnic groups. These individuals convert codeine into its active metabolite, morphine, more rapidly and completely than other people. This rapid conversion results in higher than expected serum morphine levels. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE1B382B-9F39-4CAA-8A59-17376ED6F061"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:29951346-424F-4492-B79A-EF5022CB7F05"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EEA90F54-8E00-4B5E-B685-11848BFBA55A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Numerous factors, alone or in combination, including changes in diet, medications, botanicals and genetic variations in the CYP2C9 and VKORC1 enzymes (seeCLINICAL PHARMACOLOGY,Pharmacogenomics) may influence the response of the patient to warfarin.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:964EBF55-DC67-43A9-93E2-DBC843BB8D2A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FE990D63-4739-43A5-B062-7A946346B2AF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FED638A3-F491-4246-B5EC-651C306CF76E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:147B38AF-9E51-4D8A-B5CF-D7FAE7375257"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Tamoxifen decreased the incidence of small estrogen receptor positive tumors, but did not alter the incidence of estrogen receptor negative tumors or larger tumors.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">HLA-B*5701</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8E738FB7-477C-4524-B024-29343F2936EA"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7084C584-8C84-42A3-AFAB-F66F243A2817"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8B50CE5B-C2BB-4D97-838E-E1C2600020BC"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:3C75F25B-730C-424C-8A4A-C55F0D242716"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:BD33E8D1-8AEF-4E43-9C57-35AB0263305D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE521BAD-75B0-418A-A885-F72D473E4567"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:B6B4A58C-16B0-408F-A838-47FC8649B72D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BF8C1810-3B2F-446D-95FB-F6382AEE1DC0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CARBAMAZEPINE-ee15d911-73c7-4bc6-96f2-089a8aa64e18.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0DA7AAE6-C82C-4935-9D33-40D96FDB2416"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> The variant alleles CYP2C9*2 and CYP2C9*3 result in decreased in vitro CYP2C9 enzymatic 7-hydroxylation of S-warfarin. The frequencies of these alleles in Caucasians are approximately 11% and 7% for CYP2C9*2 and CYP2C9*3, respectively1. Patients with one or more of these variant CYP2C9 alleles have decreased S-warfarin clearance (Table 1).</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:15924106-592A-47E7-A01C-764A16E257DC"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0ED7B264-E15A-44A2-9037-2D21B5180CD2"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Discontinue ZIAGEN as soon as a hypersensitivity reaction is suspected. Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:99AB6350-6929-4C24-B144-7B97EBF09B3F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommended</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">one non-functional allele (heterozygous)</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C852929-ADD4-4383-A351-2D9CF492A6E9"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:39:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1DB91157-FBA4-4FE0-BAB1-68BB8A5A145E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D640727D-6442-4274-B453-64F04BD595E3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:E826D255-0A7E-4F3C-A59F-675E8A9B606E"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:29A5252E-79CA-41F6-BF34-26789C947F8D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:30201CA6-94D8-4A83-9451-AF1497A97E75"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:51C4FEDD-5F25-4F57-92BC-5456BC2E4846"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:32:07 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 12:18:51 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6A2E1BD4-3863-4A37-AD9D-6B54F3CF3E54"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EE534BB0-3042-44F4-9B63-01291E28FA45"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:216A1896-63FD-45FE-ACBB-80F82EB9ACE5"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BCC8E4C0-518C-4CB7-86BA-64CE75086359"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ECE9E8AD-BAEE-4FC0-A880-67D03D8D2EED"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:875F6756-255E-43CC-8CA5-19D63561F59A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:3542</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2423954D-96B2-404E-8B04-9609825C795A"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7673EC96-E39E-4D34-A8B6-A31AD2825C94"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38B0D49A-8B7C-4D71-B2CE-0388425D3B66"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:398416DB-3813-458C-AEAD-1E703244DEC7"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:ABB77F0A-DE6D-4F3D-87F3-CFA59807AA63"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E7B4486A-24AB-4642-ADB0-B78FF5AF0E42"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1A89E704-ECDB-4495-8848-DB89566FFC2E"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">For HLA-B*5701-positive patients, initiating or reinitiating treatment with an abacavir-containing regimen is not recommended and should be considered only with close medical supervision and under exceptional circumstances where potential benefit outweighs the risk.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:461FDA58-8FAB-4951-B04A-F969D73C634D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D92166A3-0B32-4545-B4CA-719FEDAF410D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE76789E-AB5D-4F50-AF22-F3C2D4249992"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Efficacy</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4C36F11A-E282-4BFB-849D-B93A233A50FB"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44E81086-BA17-4D23-BE19-3D545D7F1B9D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38655F0E-DB25-4C1E-A99A-7E2B18134930"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:01:24 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Citalopram</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:88C2CEB5-469C-451E-8436-788ABE4338F5"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:4A5BB36A-D20C-4306-8958-609D3F9A13D0"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2446A882-2020-42F8-AD24-FE3B4F839958"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:136CA05A-B32D-4CAF-B985-0FB9EF4F0455"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:231E14A4-5E1D-443C-B50C-8E3E00BBAF15"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">ultra-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9837A225-376D-44A6-959D-05A7DCB03CCE"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:121CDD92-5195-42C0-A613-F40D095DA06D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">extensive-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4CFDD438-5250-4D24-9933-43397A6F2E0F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:95EEC2FF-D292-48FE-8FD7-FEF64E2F00E4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D66FA8C3-8BAB-4A6F-8234-6DD134876578"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1A9E2879-AD9B-48F5-B672-AB5C06A28080"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0AB99582-A22B-403F-9604-C35A9897CE91"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9E9B14EC-233F-4ABE-B627-6150C0C5A5A4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:720C5233-AF5F-4538-891A-259FD3EE6895"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BCCF3F22-38AE-4F01-87D0-22C1B07EC947"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C9</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:DoseSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Decrease from baseline</n0pred:DoseSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">TPMT*2, TPMT*3A, TPMT*3C</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7C3837BB-DAF7-4544-9D2C-A63E2F406BAC"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:72D8F9E8-4B4D-4FC2-81A2-A19C5BF05098"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#"> Patients taking ZIAGEN may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of this allergic reaction is much higher if you have a gene variation called HLA-B*5701 than if you do not. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:151DFA13-B2DF-4857-AAE9-51CADEC9A12F"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:46C63D3B-0000-404E-BC76-FB01C42DC7B2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C09E3379-98EF-4D6C-8046-8C000B4A6C99"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9258FFBC-DCDC-4C6C-A375-9FC03C323B54"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10B1EB06-38FD-41C2-A3B7-625B2825B889"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Letrozole tablet is an aromatase inhibitor indicated for: \nAdjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer (1.1)\nExtended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy (1.2)\nFirst and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:671F2493-9F0B-4BB9-94E6-4B432F418763"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4D27D69B-2F63-4940-AD74-710454AA1E6A"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5949C0ED-ECE8-4C36-B91D-8E58F7A36AAC"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:22:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:82F247F1-5E0B-472B-8C42-4074C2A25CD0"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CITALOPRAM-16bda7b5-a5a5-4478-9df3-beb396bd677f.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:481D46BB-D4FB-4587-B147-C2FC166A7A51"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Warfarin is thought to interfere with clotting factor synthesis by inhibition of the C1 subunit of the vitamin K epoxide reductase (VKORC1) enzyme complex, thereby reducing the regeneration of vitamin K1 epoxide. The degree of depression is dependent upon the dosage administered and, in part, by the patient&#39;s VKORC1 genotype. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01006</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:33D89E0F-4370-431E-8DB5-094F3AF78C75"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/AZATHIOPRINE-040d010a-b1b2-4db7-905d-8aa7f1bab0cd.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E719DBCC-60BF-47C9-A2A6-B5AD564ED472"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2625</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:59E6E4F8-DCB3-4875-86B2-D5885FD80EF7"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3CB531B1-A267-4A03-A0C5-D852AB638802"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:35:45 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Again, refers to increased exposure; we infer metabolism.  Said decrease from baseline as added a max dose.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:7FD03E69-B442-41B6-B8EB-38BD572E8F45"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:977E5F5B-8852-45BE-A6FC-8DEB91191DED"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D62A1217-AE83-41D2-B678-FDCD04344D8B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:13:30 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BDEED6AF-6C6D-44F0-8470-40D3A54778C5"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A903F38F-38D4-4052-A673-7FF19407E3DB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2CE69763-0812-4DFF-A359-2A8D8FF706AD"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2083D2DB-07EF-4969-A4BB-F5823A134875"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F880CCED-A2A0-4330-B02F-070F7BF5AF00"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:AE6AF907-607C-4B15-B108-FAD4D3010CA4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F54825B6-3CF9-4465-A4BE-7C6747734A6E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1532F8ED-1CF3-45D5-8A36-00FA8FD6060D"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8CD7F86F-C041-47B7-B7D2-F7B48F523F56"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Before starting ZIAGEN, tell your doctor about all of your medical conditions, including if you:\nhave been tested and know whether or not you have a particular gene variation called HLA-B*5701.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:74EB8F8A-FCEA-41C8-BAB2-B4DFA1190D34"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Increased Toxicity Risk</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE1DC1EA-085A-4CF9-8165-5A14A411A633"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1B973C15-149D-4D98-90E2-4A06A2F30ABD"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006120</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0A10CE73-592A-4D92-84AF-63395C43C0F9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3A77F5FE-EF65-4FF1-9BCD-E358D4D5BC82"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">low-or-absent-activity</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9C09D2F8-83BE-446D-A17A-75402666EE4B"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F45F585A-05C5-49B5-BABB-73BFBE9E9753"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ER_receptor</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B79BAC9C-6B3B-4FF1-9F24-2BD40CE200BF"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">A double-blind, randomized, placebo-controlled trial of letrozole tablets was performed in over 5,100 postmenopausal women with receptor-positive or unknown primary breast cancer who were disease free after 5 years of adjuvant treatment with tamoxifen.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B00F626B-2496-40FE-8B44-A026746EF9DB"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Approximately 8% of Caucasians lack the capacity to metabolize CYP2D6 substrates and are classified as poor metabolizers (PM), whereas the rest are extensive metabolizers (EM). PMs have about an 80% increase in aripiprazole exposure and about a 30% decrease in exposure to the active metabolite compared to EMs, resulting in about a 60% higher exposure to the total active moieties from a given dose of aripiprazole compared to EMs. Coadministration of ABILIFY with known inhibitors of CYP2D6, such as quinidine or fluoxetine in EMs, approximately doubles aripiprazole plasma exposure, and dose adjustment is needed [see DRUG INTERACTIONS (7.1)]. The mean elimination half-lives are about 75 hours and 146 hours for aripiprazole in EMs and PMs, respectively.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BEFD527-0C92-4B61-A2B9-12F931EDC707"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FC7D109F-F404-4287-BE4A-D7C5AA057401"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 08:58:47 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:Prodrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Prodrug</n0pred:Prodrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*1502</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8BDFDC96-47AF-489E-8F96-DF9B26C6ECBE"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EED39F7C-032A-4628-9022-2253559E7FEE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5D85FB52-BA95-409A-8974-2E14C9527722"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:905B00B5-CD9F-4F5A-BDCD-2E0771AC9B73"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34066-1 BOXED WARNING SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34068-7 DOSAGE AND ADMINISTRATION SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98B929B0-EA85-44FF-B8CA-9D5AC804EBBB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D32E2B19-3891-4F8B-98F3-B65344B0F6A8"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A460766E-6EF1-468A-A8D7-D8163DEDE490"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00675</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:79AEDAF0-0AC0-4A44-9F6D-05B14ECEF74F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C44EE5A-5A11-4743-B389-617115FC82BB"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:58D07047-AF21-4623-8E4E-4CB2945F5986"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9DCD19CE-D636-45D6-B994-A9BDBCA32621"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Increase</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:ED9FC62F-6F5A-4AEC-B2EB-900F4C21E312"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60281E0C-D291-4163-9B6F-E83A4142CB8E"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 12:25:24 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB3C226D-314F-473A-AA0D-98DCD192D7AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9982EFEC-057D-47A7-8241-37ACB3F049AA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B8BA0ADB-2437-4F14-9102-2EC16B13EE4C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:PharmacodynamicImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Influences Drug Response</n0pred:PharmacodynamicImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B3811262-7FB7-4610-8AF2-DDBEC1F3F734"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0E9FF6AD-98CE-4932-AD5D-E657F3B363B3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:878D746A-3252-462C-AA1E-A857E2FC63AF"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:34:53 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CD7BE61C-D111-48EB-A232-1241D41AB8BC"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A753145C-8800-49A8-BE99-D558A1390DAE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:169DB9DD-C966-431C-85FE-C3AC1F8E31D3"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E34142C5-1680-4612-AC76-D96D8F82364F"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2BB0E9F3-52F1-4631-B37B-DBFB53B3B0C9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:933C6C55-0C1F-4A1C-B72F-98683FD68184"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2386BDBC-D4E5-43AD-9B96-93D7943C7169"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CA5A93F5-5D2A-44BF-8951-9EF6DFE12F1B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:01:50 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F5C240E5-0680-4CDA-ACC9-4DB8C5A0984B"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:01:43 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A24FCBC0-9830-43DC-87D5-5716D3136B02"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01238</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">add test result to drop down; check search of location using magnifying glass to make sure it comes up correct. It should be the same as the next one with and additional sentence for intermediate metabolizer.</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0B3E23EF-1696-4FF7-BEEB-8158BDA84294"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:87D0F0C2-6038-41AA-B84E-85497D292836"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7FA5409D-3EA5-4F92-B738-8577DCEB4D97"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:375DD3AE-F16E-43E9-BB3E-D521613E10AF"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">In the Hubay study, patients with a positive (more than 3 fmol) estrogen receptor were more likely to benefit.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:558D142F-DBE9-4EB9-9F46-4244D63F2FAF"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:98743D23-3B02-4029-840D-D16A4F390F95"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:139D3D04-C6A8-40B1-A6F1-5FBFB1B6B7CE"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:25:55 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:83E53A9A-8702-4167-A12D-1370E2D26E06"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:28:28 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:08308CA2-E50D-41DB-873B-E57372B5FBDB"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00215</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3D5D3473-95BD-41AF-81E6-ED19E81798E9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3C70DFC4-2BEA-46AE-A49C-D4BE3E7466B8"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:29:31 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D2A8C2D7-9A3E-4307-BC2B-4EA4FC30E8A5"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34092-7 CLINICAL STUDIES SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:407F8565-3B9C-4CF8-B785-C8286BCD86A2"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">42232-9 PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1E6D8BE7-AC23-449A-83E2-9806683F8162"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5C1D543-12A2-4AD2-973F-CFDA436726C9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:0B13BA6D-FAED-4224-BF7E-64E31E595AD6"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Not necessary</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:31115D88-2436-4D8C-B5E2-A7636A9DA498"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D6235B22-042E-4C36-A104-B353CF92CEB8"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7CE2D02E-F446-465D-9CBE-27C213ACCC89"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2510C893-9155-453B-922C-CF116136DD88"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add test result to drop down</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">VKORC1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5630014D-C820-4E31-A061-529A1A06548B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:94B53E9F-5329-43D3-AD42-03C430F6E877"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:05DBF40D-ECCF-4BC6-9077-742EBADF41F9"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6E680A49-5B91-4058-A09E-25A6ED988EFC"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D03D6753-24D2-4897-9947-4D727F406A9D"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4777BC06-68FA-4171-A52D-68668AD25547"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B2CCF84A-A981-4564-8227-DE5688CB1FED"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:10:10 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C904A0A3-252D-4872-B966-44B63E18E430"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F2C1F1F7-17ED-4AE1-91F9-3A2EE9802A65"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">WARNING: DEATH RELATED TO ULTRA-RAPID METABOLISM OF CODEINE TO MORPHINE\nRespiratory depression and death have occurred in children who received codeine following tonsillectomy and/or adenoidectomy and had evidence of being ultra-rapid metabolizers of codeine due to a CYP2D6 polymorphism.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><n0pred:hasTarget xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:6FC50BDC-78A6-4D50-8D6E-7FEB6DAFF0E2"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1908624-6F0B-47BD-8D70-8EACD877F4A9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8F4ED235-6F4A-4BDD-A23F-6F2D9FC7A396"><n0pred:hasBody xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:linkedspls:uuid:6F731CE1-E6B4-41AA-98C6-30C94B771E61"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:MonitoringRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Required</n0pred:MonitoringRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B7B25E99-EE57-41AC-BDE2-45DCC1447471"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D66A54D7-BD47-4E22-B2F3-09A5D190955A"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">F5</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:910F9AE9-8398-400D-8505-D971512A67C6"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:224ACECA-832C-4CE1-B586-4BB3E2AC8018"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Retrospective case-control studies have found that in patients of Chinese ancestry there is a strong association between the risk of developing SJS/TEN with carbamazepine treatment and the presence of an inherited variant of the HLA-B gene, HLA-B*1502. The occurrence of higher rates of these reactions in countries with higher frequencies of this allele suggests that the risk may be increased in allele-positive individuals of any ethnicity.\nAcross Asian populations, notable variation exists in the prevalence of HLA-B*1502. Greater than 15% of the population is reported positive in Hong Kong, Thailand, Malaysia, and parts of the Philippines, compared to about 10% in Taiwan and 4% in North China. South Asians, including Indians, appear to have intermediate prevalence of HLA-B*1502, averaging 2 to 4%, but higher in some groups. HLA-B*1502 is present in &lt;1% of the population in Japan and Korea.\nHLA-B*1502 is largely absent in individuals not of Asian origin (e.g., Caucasians, African-Americans, Hispanics, and Native Americans)</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4743B32B-A374-4701-B3BA-DD766AB522F6"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:1FCB6C74-C406-41C1-8A44-C9D033D5834C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B4C9D47-E3BF-4D75-A661-0D5A649108C6"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75D456DC-1DB0-4F96-A11F-551CC8425889"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:44A37F21-E420-40D5-A9E0-5CEDEFAEF40B"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00758</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3746E014-4500-4C39-A007-7B912571A900"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:10D9A112-25CB-425E-899B-C3AAA3CF633A"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">If you are of Asian descent you may need a genetic blood test before you take Carbamazepine Extended-Release Capsules to see if you are at a higher risk for serious skin reactions with this medicine.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0D044EC4-5762-411E-A3D7-4BF4908C494F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-28 15:54:29 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:599459E0-8D98-4627-BC38-BA5B6BEC6B33"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:201331AB-54CD-4BE2-81C9-806CCB6E5915"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:EF919E4C-C0B0-4D8B-A273-2F4A806A828D"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:84646AA6-8E85-4656-8515-E49CB15EADB4"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9692B313-0E4E-4D52-9D7C-456D2EE68F54"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:27F9E2A8-C54A-4F87-A02D-4F8EFF5D382F"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53541A7F-ACF6-4030-A4B7-7BA865CDF82F"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7BC21EEB-9DB7-4481-AB5F-CDF2B8C45D96"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:745C184B-12B3-435F-99C5-252556EB53B9"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:3846BD3B-067C-4D62-AAA4-6A53131A2A2B"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7B209F2D-47BE-4267-B895-92D67A47AE61"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:45EDCED8-9B43-464F-AC7F-898A9009649D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1DA28968-6C74-475E-AB4F-5E6E22DFF8BD"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:56D95EC4-D0D7-4BD6-B13C-E145F6A4E568"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-level-low</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:850F3B60-ADC8-42A5-8E7E-B50B1E9D39BE"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Tamoxifen</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6F41EB64-7E4B-4DAA-86FE-348F6836D46E"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8431F83B-801B-499C-A34F-25B983A4B198"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/LETROZOLE-63e54b62-a30d-4a56-9215-75e7a0b0bf02.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5D87AC20-773F-4241-AA52-57BF86A4A93A"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:03:47 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8026784E-DC9A-4F18-963D-495E0532BB97"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:45B95464-0287-435F-86B4-0253D73E6DA8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CE483709-CD8C-4493-A2B7-8E589B98BF31"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:6E7BEB44-17B2-4A01-8866-7DAFBEA17CC6"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Discontinue ZIAGEN as soon as a hypersensitivity reaction is suspected. Regardless of HLA-B*5701 status, permanently discontinue ZIAGEN if hypersensitivity cannot be ruled out, even when other diagnoses are possible.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:39A685C2-1AA3-415F-8F2F-3F82C6914A2D"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">WARNING: DEATH RELATED TO ULTRA-RAPID METABOLISM OF CODEINE TO MORPHINE\nRespiratory depression and death have occurred in children who received codeine following tonsillectomy and/or adenoidectomy and had evidence of being ultra-rapid metabolizers of codeine due to a CYP2D6 polymorphism.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:AC5F1BAD-8B6A-49DB-8147-AB1394EC169F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:53B64B1F-739B-46F0-99EE-89EF4131A8D2"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00318</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:8BEEBA62-C519-4421-9038-113DCDFC9B2C"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F23E4DD-C825-4CCC-BD6E-1514188AFFA7"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B30B41E3-5A67-4530-BC81-938E6B016FDF"><n0pred:MedicalCondition xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">MedicalCondition</n0pred:MedicalCondition></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F9A68240-FAD6-4604-8DEE-1B0E4AF9BD21"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7E666CF4-DD19-4B4B-AE7B-EF4BCEA0181C"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">34081-0 PEDIATRIC USE SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FBA8BE44-2409-4673-8D2F-0E2947538FCE"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen citrate tablet therapy.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:76AEC8EC-841B-4618-8A97-4D6655CE39F4"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4F5C1D0C-9AFC-4B3A-83EC-AC9CB72FB0C9"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C89E80EC-0820-406B-99C8-D495EC5F054E"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-02 14:03:56 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D5CF7A64-E07F-419A-8900-15F969F2D51F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-31 09:05:56 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E06F2653-44AD-435F-AB2C-133712B039A6"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00564</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-03-22 22:15:05 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9F45C51D-C093-4FEB-A57B-7D59EB1E01DA"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:61BA8ACB-D63A-46FF-8B5D-79E9326A61A3"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/WARFARIN-3d35df36-1a19-4559-91fe-252b7082295b.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5E02C5AB-C35D-4ACA-8EF0-DF0F481E6A00"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*1502 </n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:36FDCB4E-5E54-4CBA-BC44-04B836C019F0"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B9375CD1-7E67-42D6-B380-D95AD08BF64B"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Warfarin</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:141D5512-1FE5-4684-BAA6-CA59DA362006"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FB8FC7BE-DF14-4ABF-B790-607DABB38F49"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:07:33 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:25348450-1CCF-4BEC-84EF-0EA92F67DD3A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:5239657F-5948-4803-B690-76D953D60764"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:402D9368-C611-4289-8004-8EEC1A409CCF"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855BF4FE-7082-466C-AEC2-BA37C5A2F93C"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4B11E300-2DF5-4B21-9D43-4D0A02109A59"><n0pred:TestRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Recommend</n0pred:TestRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:Variant xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer</n0pred:Variant></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:38CB7B79-EA55-443D-8F52-A694D541E5E3"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3728C2D2-73B4-4F3A-A648-FD42247BA4EE"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBCD24FF-6ABB-4810-A5CA-DF8F85FF2241"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:BBD1EA14-A142-47FF-A3B5-D848FFAED44F"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">STUDIES IN PATIENTS OF CHINESE ANCESTRY HAVE FOUND A STRONG ASSOCIATION BETWEEN THE RISK OF DEVELOPING SJS/TEN AND THE PRESENCE OF HLA-B*1502, AN INHERITED ALLELIC VARIANT OF THE HLA-B GENE. HLA-B*1502 IS FOUND ALMOST EXCLUSIVELY IN PATIENTS WITH ANCESTRY ACROSS BROAD AREAS OF ASIA. PATIENTS WITH ANCESTRY IN GENETICALLY AT-RISK POPULATIONS SHOULD BE SCREENED FOR THE PRESENCE OF HLA-B*1502 PRIOR TO INITIATING TREATMENT WITH CARBAMAZEPINE EXTENDED-RELEASE CAPSULES.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A48D46C7-8F7E-4426-8C3D-CCA08F946DB0"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:8C0132CB-1BA7-4320-8C5F-E55761BC596E"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:43B85AB2-533A-4A3B-932F-7CD7177449ED"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">WARNINGS AND PRECAUTIONS (43685-7)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DBBF90A0-6468-4792-B1CC-02DDD21B4A08"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:7AE1124F-F104-4EB3-9415-257F81B2E3CE"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">PATIENT MEDICATION INFORMATION (68498-5)</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:09071EE6-03DB-49CA-BA67-1589B0E2FDBD"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0961EB1D-39A9-4A01-9D9B-C2BC3222987E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B6570F9A-45F9-4786-BDA7-9D6B899F45DB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:0496C268-8D3F-4D44-95D9-8D7250579EBE"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Prior to initiating therapy with abacavir, screening for the HLA-B*5701 allele is recommended; this approach has been found to decrease the risk of a hypersensitivity reaction. Screening is also recommended prior to reinitiation of abacavir in patients of unknown HLA-B*5701 status who have previously tolerated abacavir.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:A1F7627F-2636-46AA-A344-F9978C2AA71C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clopidogrel</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:87B8F5B0-8381-4CA7-AE0B-30C481D164B4"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBD3A076-17BF-416E-9EEC-89C39FD558A3"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1FAA2AB1-96D9-4225-A9E1-763F045EE2CD"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Azathioprine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:976BDFF3-2BFA-4838-B6A0-327B2921E1B7"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">The CYP2C19*1 allele corresponds to fully functional metabolism while the CYP2C19*2 and *3 alleles are nonfunctional.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2621</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D26DCABA-C665-4147-A57B-F26195C0188E"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">biomarker-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E6B02E4B-FDE8-473A-A978-02F98D0FE07D"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9A074D82-152F-415F-84A1-93EDCC8179B1"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/CLOPIDOGREL-03bec9ad-cd22-44d3-9b82-2796157de1d1.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9A15D029-5B02-4107-A829-E2BD1B1219FE"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">poor-metabolizer-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2D0B9A22-6129-4786-B0A4-7384B3324DF0"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00682</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:CE3D1055-4EAF-4F2F-A2ED-AA9B95C45024"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43685-7 WARNINGS AND PRECAUTIONS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:92FA8990-60EF-4140-9F60-C12E57E3B114"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">ESR1, PGR</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:35B89AC4-DAE5-4207-B319-F9479AE77CDE"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.0alpha-040</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F5AE3B3E-B864-4A19-B48C-DC1343C799A3"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:E17574BF-3BA6-48DA-B0DA-6E8DF716A03D"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5A997B78-0557-4495-BDBD-42F5B4B30412"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5D7649B4-7723-40DE-B9AD-4926156D8C0A"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-21 13:23:42 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D3EDFFC9-9EE3-45DD-B147-801DAB72DF3D"><n0pred:SIO_000111 xmlns:n0pred="http://semanticscience.org/resource/">43682-4 PHARMACOKINETICS SECTION</n0pred:SIO_000111></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:C2A76A18-A463-4D7B-9A00-33BEFE84F768"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not start</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D64C9075-1FB5-47EA-9312-70A065865D71"><n0pred:PharmacokineticImpact xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Metabolism Decrease</n0pred:PharmacokineticImpact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:403ED560-E6D3-4B1C-BAF1-DD0E0D87AA3F"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Tests are available to identify a patient&#39;s CYP2C19 genotype and can be used as an aid in determining therapeutic strategy.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FEF94E24-725D-433B-8F55-9E75E14CECB9"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:FA0C425E-2A1E-4059-BAC2-34BD4239836F"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">In the NSABP B-09 study in women age 50 to 59 years, only women with both estrogen- and progesterone-receptor levels 10 fmol or greater clearly benefited, while there was a nonstatistically significant trend toward adverse effect in women with both estrogen- and progesterone-receptor levels less than 10 fmol. In women aged 60 to 70 years, there was a trend toward a beneficial effect of tamoxifen without any clear relationship to estrogen- or progesterone-receptor status.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Carbamazepine</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:009DEEE9-9289-445E-8C79-81457BE96692"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:691E83A1-1BFF-4939-996A-35C56D0CF2DF"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:75C4424E-2C9D-40D9-82CF-7E02CFDCA301"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9F0CE910-4782-4E6D-B7E2-C7C784B10B90"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Limited evidence suggests that HLA-B*1502 may be a risk factor for the development of SJS/TEN in patients of Chinese ancestry taking other anti-epileptic drugs associated with SJS/TEN. Consideration should be given to avoiding use of other drugs associated with SJS/TEN in HLA-B* 1502 positive patients, when alternative therapies are otherwise equally acceptable.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB01048</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:81525CE9-0714-4D48-9149-6C8B8671E117"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BF7AF633-8B36-41BF-AC4F-0BA548A0DB2F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:2EDDDF15-34C4-4321-9EF6-7ACDEBEFD237"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:23:14 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000002010</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:13F3B206-EA87-463E-9DA8-93AA056A9117"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Discontinue/Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4663B6D5-B11D-4039-8F32-F7E3BFC2537E"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:40B2A403-27A7-43FE-A0AC-5D87E3545981"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:15:04 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEE1B9FD-09F4-4AD6-9BEB-55CF10F2FDDB"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:F0B7C43C-792D-49E5-B282-D2303F858889"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12530</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BDDF82-70E1-44A8-B130-17D04DE86798"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:6B9F2EDD-8EC9-441C-9B9C-6DE4ED079F50"><n0pred:pharmgxDrugURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://www.drugbank.ca/drugs/DB00993</n0pred:pharmgxDrugURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:A3C1B92C-CBE0-4BA8-A41C-D3C3CD26FA51"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000016583</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:42FA1C17-B780-423F-B993-EAF8D8DF0329"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B*5701</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:B24A699D-7127-47C1-BFAE-C1ABB6819E2F"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:8D91E7D5-B379-4649-9834-0D01A948DFF8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FC766D1F-0C5B-4C57-8386-30CC6B3408B5"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DEA4B73A-145A-4D61-A6E1-ABAE37F63480"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:36:29 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74BB3F3E-AD24-438C-9250-4357E959069E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:23FACDDB-003E-40B5-AB79-B52F5FD124B3"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-09 15:55:39 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9BD38C7E-B2D9-4C83-903C-F86556F46EF2"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Letrozole</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:69B50E0E-4BB4-49DC-AE8B-4326D0F0A959"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:89320F5F-262D-4657-8A52-4432EC0101F8"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:4DD1AE8C-CB2C-4887-993E-A8A44B2A06CB"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">TPMT</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D939C426-7E0B-4A32-80F1-7344D702AA97"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2C19</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:43CE071E-85A3-4BC0-AEAC-4FC4DCBB3D02"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:055AAAC1-3544-4B8E-BF06-C99328A12B6E"><n0pred:HGNCGeneSymbol xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">HLA-B</n0pred:HGNCGeneSymbol></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4364906C-8414-403A-BB1D-1DDCC5F6A4DA"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:5B91F78A-EEB0-41A3-8995-90B920D09520"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:24265221-E0B1-4F13-A2EB-0E9D9DC6F5D4"><n0pred:ClinicalTrial xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Clinical Trial</n0pred:ClinicalTrial></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><n0pred:Alleles xmlns:n0pred="http://purl.bioontology.org/ontology/NCIT#">HLA-B*5701</n0pred:Alleles></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:CF35511B-7BED-446A-B970-33FEE5C13C88"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:E03CFE71-0FEF-4840-A587-1D360CBF035C"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:3616601B-9F53-4ECD-985B-8205444D8F7C"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000007205</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:C1BF7FF6-707B-4750-BA47-274111148F96"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:7E2CB9FD-6E66-4D71-8B92-4AE2C557E1A3"><n0pred:hasSource xmlns:n0pred="http://www.w3.org/ns/oa#">http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/ABACAVIR-6a3b10fc-4b2a-45e3-16a1-ef79187a6dfb.html</n0pred:hasSource></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:9739D8D8-F16D-4FF9-BD63-1945B116EEC4"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:74EA2B44-40D9-44F0-90BA-33EFF2D1B5AA"><n0pred:pharmgxDrug xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">Abacavir</n0pred:pharmgxDrug></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0D634683-D28C-42DC-9911-DFD0C9EB289D"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:4932</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:5229A912-1F9A-40AD-9994-79886D701F6C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:763ABA1D-A316-42DE-AA02-A7123411CD6C"><n0pred:Comment xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Add drug selection recommendation of &quot;indicated for&quot;</n0pred:Comment></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:B35B25D3-31CE-48B5-885E-844B46E97203"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 15:04:17 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:855697DF-EBFA-4343-B2F2-023B6F284D48"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:12014</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F498E725-B59B-4357-806F-4F316B1EAB6C"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:EE8AF84A-98F2-4EED-8B54-4312A50FBA31"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"><n0pred:hasSelector xmlns:n0pred="http://www.w3.org/ns/oa#" rdf:resource="urn:domeoclient:uuid:9C2B48AD-A4E0-4C6C-9246-E6FD6CF712C8"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:420A3DFE-8247-4E9B-8E6C-368F1A2C415C"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-04-14 14:25:51 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:4BED623F-9685-4D95-8EAD-FDE3617D193B"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:68B37481-F382-41B9-AEF5-DB241FA9325F"><n0pred:pharmgxBiomarker xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">CYP2D6</n0pred:pharmgxBiomarker></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:524C3AB2-2955-4538-A46C-63CDD0BC11D2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:396CB021-3C85-4E20-B020-3714CE558E2D"><n0pred:VariantFrequency xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Variant Frequency</n0pred:VariantFrequency></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:FBEDA24D-50C7-407C-9337-9A08D9456999"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:2623</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:52601F35-C2AB-4602-BD13-6B9999A0266A"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-positive</n0pred:TestResult></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:60CFE292-6834-41FC-8255-B81A3D584EE2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:D3CF5A34-A1A9-4AFC-83F2-A5A1DD6DBB7F"><n0pred:createdOn xmlns:n0pred="http://purl.org/pav/">2014-06-30 13:16:49 -0400</n0pred:createdOn></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:616A0715-5B79-4DD8-8392-1FDEF99E9911"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">Patients taking ZIAGEN may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of this allergic reaction is much higher if you have a gene variation called HLA-B*5701 than if you do not. Your doctor can determine with a blood test if you have this gene variation. </n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:90E4AF52-01F4-4371-B3ED-D400FF8B1C1E"><n0pred:createdWith xmlns:n0pred="http://purl.org/pav/">urn:domeo:software:id:Domeo-2.1alpha-050</n0pred:createdWith></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:D1D85749-709E-4FD8-A464-C8E7CD8158BB"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006102</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:F0BBC254-D123-49BE-A254-67148370DC96"><n0pred:exact xmlns:n0pred="http://www.w3.org/ns/oa#">CYP2C19 poor metabolizer status is associated with diminished antiplatelet response to clopidogrel. Although a higher dose regimen in poor metabolizers increases antiplatelet response [see Clinical Pharmacology (12.5)], an appropriate dose regimen for this patient population has not been established.</n0pred:exact></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:2185EE39-FD81-4C83-ABDF-E5D59B789F96"><rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:1769615F-FAC0-4900-9DC6-5021630F8524"><n0pred:HGNCGeneSymbolURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://bio2rdf.org/hgnc:8910</n0pred:HGNCGeneSymbolURI></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:0BEDE64D-11D3-4746-9532-E747F6A427E0"><n0pred:DrugSelectionRecommendation xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">Do not restart</n0pred:DrugSelectionRecommendation></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:071CEC58-02E9-4DA2-8259-93E87A6EFD3B"><n0pred:pharmgxBiomarkerURI xmlns:n0pred="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/">http://purl.obolibrary.org/obo/PR_000006121</n0pred:pharmgxBiomarkerURI></rdf:Description>
<rdf:Description rdf:about="urn:domeoclient:uuid:DF92C1E1-A223-4737-8028-06DD03B558D2"><rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/></rdf:Description>
<rdf:Description rdf:about="urn:linkedspls:uuid:BC70D092-5124-4A5C-87C3-EA34E4868C05"><n0pred:TestResult xmlns:n0pred="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#">gene-haplotype-negative</n0pred:TestResult></rdf:Description>
</rdf:RDF>